Glycogen storage disease type I other imaging findings
|
Glycogen storage disease type I Microchapters |
|
Differentiating Glycogen storage disease type I from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type I other imaging findings On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type I other imaging findings |
|
FDA on Glycogen storage disease type I other imaging findings |
|
CDC on Glycogen storage disease type I other imaging findings |
|
Glycogen storage disease type I other imaging findings in the news |
|
Blogs on Glycogen storage disease type I other imaging findings |
|
Directions to Hospitals Treating Glycogen storage disease type I |
|
Risk calculators and risk factors for Glycogen storage disease type I other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Dual energy X-ray absorptiometry (DXA) may be helpful in the diagnosis of osteoporosis and/or osteopenia due to poor metabolic control in patients with glycogen storage disease type 1. Findings on an dual energy X-ray absorptiometry suggestive of osteoporosis and/or osteopenia in patients with glycogen storage disease type 1 include low bone mineral density (BMD).
Other Imaging Findings
Dual Energy X-ray Absorptiometry
- Glycogen storage disease type 1 with poor metabolic control develops osteoporosis and/or osteopenia which is associated with low bone mineral density (BMD).[1][2][3][4]
- Dual energy X-ray absorptiometry is used to diagnose low bone mineral density (BMD).
References
- ↑ Minarich LA, Kirpich A, Fiske LM, Weinstein DA (2012). "Bone mineral density in glycogen storage disease type Ia and Ib". Genet Med. doi:10.1038/gim.2012.36. PMC 3884026. PMID 22481133.
- ↑ Cabrera-Abreu J, Crabtree NJ, Elias E, Fraser W, Cramb R, Alger S (2004). "Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX". J Inherit Metab Dis. 27 (1): 1–9. doi:10.1023/B:BOLI.0000016632.13234.56. PMID 14970741.
- ↑ Rake JP, Visser G, Huismans D, Huitema S, van der Veer E, Piers DA; et al. (2003). "Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study". J Inherit Metab Dis. 26 (4): 371–84. PMID 12971425.
- ↑ Schwahn B, Rauch F, Wendel U, Schönau E (2002). "Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control". J Pediatr. 141 (3): 350–6. doi:10.1067/mpd.2002.126456. PMID 12219054.